2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Csl Behring: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CSL Behring Sclero XIII Fibrogammin®P, coagulation factor XIII concentrate (Human), 0.9% sodium chloride - Systemic Sclerosis | Phase 2 | Unknown | University College, London | 26 | 2015-09-01 | 2016-05-30 |
| Reversal of Dabigatran With Prothrombin Complex Concentrate Beriplex - Drug Action Reversal | Phase 2 | Unknown | University Medical Center Groningen | 12 | 2015-01-01 | 2016-05-12 |
Hemophilia B (1) · Raynaud Disease (1) · Scleroderma, Systemic (1) · digital ulcers (1)
Factor IX (1) · Factor VIII (1) · Factor XIII (1) · Saline Solution (1) · Sodium Chloride (1) · factor IX, factor VII, factor X, prothrombin drug combination (1)
Netherlands (1) · United Kingdom (1)
Christopher Denton, PhD (1) · Pieter Willem Kamphuisen, Prof. Dr. (1)
2014 (2)